{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:40:23Z","timestamp":1790930423401,"version":"4.1.0"},"reference-count":41,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,4,4]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Infant acute lymphoblastic leukemia is sensitive to therapeutic targeting by apoptosis, necoptosis, and autophagy activation whether MLL is rearranged or germline. The disease-specific form of triple death mode killing by obatoclax overcomes the intrinsic resistance of MLL-rearranged infant acute lymphoblastic to cell death.<\/jats:p>","DOI":"10.1182\/blood-2012-04-425033","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T03:10:37Z","timestamp":1360293037000},"page":"2689-2703","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":57,"title":["Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"121","author":[{"given":"Karen A.","family":"Urtishak","sequence":"first","affiliation":[{"name":"Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena Y. Z.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-San","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Hudome","sequence":"additional","affiliation":[{"name":"Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine W.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology and Therapeutics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajia","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Cory","sequence":"additional","affiliation":[{"name":"Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonni S.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Bantly","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Chun","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ming L.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology and University of New Mexico Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Atlas","sequence":"additional","affiliation":[{"name":"Department of Physics and Astronomy and University of New Mexico Cancer Center, University of New Mexico Health Services, Albuquerque, NM;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Willman","sequence":"additional","affiliation":[{"name":"Department of Pathology and University of New Mexico Cancer Center and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mondira","family":"Kundu","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children's Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyla A.","family":"Heerema","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Devidas","sequence":"additional","affiliation":[{"name":"Children\u2019s Oncology Group, Department of Biostatistics, Gainesville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Hilden","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Colorado and the University of Colorado School of Medicine, Aurora, CO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZoAnn E.","family":"Dreyer","sequence":"additional","affiliation":[{"name":"Texas Children\u2019s Cancer Center, Baylor College of Medicine, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Hunger","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital Colorado and the University of Colorado School of Medicine, Aurora, CO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory H.","family":"Reaman","sequence":"additional","affiliation":[{"name":"Division of Oncology, Children\u2019s National Medical Center, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn A.","family":"Felix","sequence":"additional","affiliation":[{"name":"Division of Oncology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111809215795900_B1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1182\/blood-2005-07-3011","article-title":"Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children\u2019s Oncology Group.","volume":"108","author":"Hilden","year":"2006","journal-title":"Blood"},{"issue":"9583","key":"2019111809215795900_B2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"2019111809215795900_B3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/pbc.24132","article-title":"Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children\u2019s Oncology Group P9407.","volume":"59","author":"Salzer","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2019111809215795900_B4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/sj.leu.2401148","article-title":"Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis.","volume":"12","author":"Kersey","year":"1998","journal-title":"Leukemia"},{"issue":"6","key":"2019111809215795900_B5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2141.2008.07100.x","article-title":"Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.","volume":"141","author":"Robinson","year":"2008","journal-title":"Br J Haematol"},{"issue":"49","key":"2019111809215795900_B6","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","article-title":"Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis.","volume":"104","author":"Nguyen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2019111809215795900_B7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1182\/blood-2009-02-205963","article-title":"Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.","volume":"115","author":"Stam","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111809215795900_B8","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2005-03-1283","article-title":"Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells.","volume":"106","author":"Thomas","year":"2005","journal-title":"Blood"},{"issue":"3","key":"2019111809215795900_B9","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-2141.2001.02603.x","article-title":"In vivo suppression of Bcl-XL expression facilitates chemotherapy-induced leukaemia cell death in a SCID\/NOD-Hu model.","volume":"112","author":"Fennell","year":"2001","journal-title":"Br J Haematol"},{"key":"2019111809215795900_B10","author":"Brown"},{"issue":"24","key":"2019111809215795900_B11","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1158\/1078-0432.CCR-08-0999","article-title":"A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies.","volume":"14","author":"Schimmer","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"10","key":"2019111809215795900_B12","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2006-07-034173","article-title":"The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak.","volume":"109","author":"P\u00e9rez-Gal\u00e1n","year":"2007","journal-title":"Blood"},{"issue":"7","key":"2019111809215795900_B13","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/cdd.2009.48","article-title":"Different forms of cell death induced by putative BCL2 inhibitors.","volume":"16","author":"Vogler","year":"2009","journal-title":"Cell Death Differ"},{"issue":"1","key":"2019111809215795900_B14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/1078-0432.CCR-08-1575","article-title":"BH3 mimetic obatoclax enhances TRAIL-mediated apoptosis in human pancreatic cancer cells.","volume":"15","author":"Huang","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"4","key":"2019111809215795900_B15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI39987","article-title":"Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance.","volume":"120","author":"Bonapace","year":"2010","journal-title":"J Clin Invest"},{"issue":"22","key":"2019111809215795900_B16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1182\/blood.V114.22.907.907","article-title":"Specific MLL partner genes in infant acute lymphoblastic leukemia (ALL) associated with outcome are linked to age and white blood cell count (WBC) at diagnosis: a report on the Children's Oncology Group (COG) P9407 trial [abstract].","volume":"114","author":"Robinson","year":"2009","journal-title":"Blood"},{"key":"2019111809215795900_B17"},{"issue":"7","key":"2019111809215795900_B18","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2009-05-218560","article-title":"Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.","volume":"115","author":"Kang","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2019111809215795900_B19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion.","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"50","key":"2019111809215795900_B20","doi-asserted-by":"crossref","first-page":"20037","DOI":"10.1073\/pnas.0709704104","article-title":"Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells.","volume":"104","author":"Wang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2019111809215795900_B21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2008-02-137943","article-title":"Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia.","volume":"113","author":"O\u2019Brien","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2019111809215795900_B22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1096\/fasebj.10.5.8621058","article-title":"The role of proteases during apoptosis.","volume":"10","author":"Patel","year":"1996","journal-title":"FASEB J"},{"issue":"1","key":"2019111809215795900_B23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cdd.2008.150","article-title":"Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009.","volume":"16","author":"Kroemer","year":"2009","journal-title":"Cell Death Differ"},{"issue":"2","key":"2019111809215795900_B24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4161\/auto.5338","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"issue":"5","key":"2019111809215795900_B25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","article-title":"Identification of RIP1 kinase as a specific cellular target of necrostatins.","volume":"4","author":"Degterev","year":"2008","journal-title":"Nat Chem Biol"},{"key":"2019111809215795900_B26","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1038\/onc.2009.51","article-title":"The autophagy effector Beclin 1: a novel BH3-only protein.","volume":"27","author":"Sinha","year":"2008","journal-title":"Oncogene"},{"issue":"6","key":"2019111809215795900_B27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy.","volume":"122","author":"Pattingre","year":"2005","journal-title":"Cell"},{"issue":"12","key":"2019111809215795900_B28","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/ncb1192","article-title":"Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes.","volume":"6","author":"Shimizu","year":"2004","journal-title":"Nat Cell Biol"},{"issue":"115","key":"2019111809215795900_B29","doi-asserted-by":"crossref","first-page":"re4","DOI":"10.1126\/scisignal.3115re4","article-title":"The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.","volume":"3","author":"Vandenabeele","year":"2010","journal-title":"Sci Signal"},{"issue":"2","key":"2019111809215795900_B30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury.","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat Chem Biol"},{"issue":"7","key":"2019111809215795900_B31","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2007-09-078162","article-title":"Bcl-2-family proteins and hematologic malignancies: history and future prospects.","volume":"111","author":"Reed","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111809215795900_B32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms.","volume":"221","author":"Glick","year":"2010","journal-title":"J Pathol"},{"issue":"12","key":"2019111809215795900_B33","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.exphem.2006.07.008","article-title":"Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.","volume":"34","author":"Camp\u00e0s","year":"2006","journal-title":"Exp Hematol"},{"issue":"10","key":"2019111809215795900_B34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00001813-199711000-00001","article-title":"Modulation of chemosensitivity through altered expression of cell cycle regulatory genes in cancer.","volume":"8","author":"Hochhauser","year":"1997","journal-title":"Anticancer Drugs"},{"issue":"9","key":"2019111809215795900_B35","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-07-1919","article-title":"Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax).","volume":"68","author":"Konopleva","year":"2008","journal-title":"Cancer Res"},{"key":"2019111809215795900_B36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-385493-3.00004-8","article-title":"Apoptosis and beyond: cytometry in studies of programmed cell death.","volume":"103","author":"Wlodkowic","year":"2011","journal-title":"Methods Cell Biol"},{"issue":"2","key":"2019111809215795900_B37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0022-1759(95)00216-2","article-title":"A simplified method for the coordinate examination of apoptosis and surface phenotype of murine lymphocytes.","volume":"188","author":"Douglas","year":"1995","journal-title":"J Immunol Methods"},{"issue":"2","key":"2019111809215795900_B38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2007.11.007","article-title":"Bypassing cancer drug resistance by activating multiple death pathways\u2014a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.","volume":"259","author":"Hu","year":"2008","journal-title":"Cancer Lett"},{"issue":"15","key":"2019111809215795900_B39","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1158\/1078-0432.CCR-10-0032","article-title":"The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy.","volume":"16","author":"Wei","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2019111809215795900_B40","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1038\/cddis.2010.53","article-title":"GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy.","volume":"1","author":"Heidari","year":"2010","journal-title":"Cell Death Dis"},{"issue":"24","key":"2019111809215795900_B41","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1182\/blood-2008-12-197061","article-title":"Therapeutic targeting of MLL.","volume":"113","author":"Liedtke","year":"2009","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/14\/2689\/1364973\/2689.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/14\/2689\/1364973\/2689.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T10:24:49Z","timestamp":1574072689000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/14\/2689\/31130\/Potent-obatoclax-cytotoxicity-and-activation-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":41,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013,4,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-04-425033","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717977349.793471263","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}